An investigation for investors in OTCMKTS:FSPM shares was announced over potential securities laws violations by Fusion Pharm Inc and certain of its directors and officers.
Investors who purchased shares of Fusion Pharm Inc (OTCMKTS:FSPM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on whether a series of statements by Fusion Pharm Inc (OTCMKTS:FSPM regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On September 16, 2016, the Securities and Exchange Commission (“SEC”) announced fraud charges against Fusion Pharm Inc and its CEO, Scott M. Dittman, among others, for allegedly misleading investors by recording and trumpeting revenues for purported sales of PharmPods by round-tripping money from illegal stock sales by hidden affiliates.
Shares of Fusion Pharm Inc (OTCMKTS:FSPM) closed on October 18, 2016, at $0.0003 per share.
Those who purchased OTCMKTS:FSPM shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com